Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (300255.SZ)

CNY 20.53

(3.53%)

Market Cap (In CNY)

18.86 Billion

Revenue (In CNY)

1.41 Billion

Net Income (In CNY)

-1.24 Billion

Avg. Volume

16.04 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
7.56-25.88
PE
-
EPS
-
Beta Value
0.046
ISIN
CNE1000016C2
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Xiaodong Gao
Employee Count
-
Website
https://www.heparin.cn
Ipo Date
2011-08-19
Details
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China. Its products include crude heparin sodium, heparin sodium raw materials, heparin sodium injections, low molecular weight heparin calcium raw materials and injections, enoxaparin sodium raw materials and injections, nadra Heparin calcium raw materials, nadroparin calcium injections, and dalteparin sodium raw materials and injections. The company was founded in 2000 and is based in Shijiazhuang, China.